This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Guideline

. 2005 Sep;52(9):2607-15.

doi: 10.1002/art.21291.

International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies

Chester V Oddis¹, Lisa G Rider, Ann M Reed, Nicolino Ruperto, Hermine I Brunner, Bhanu Koneru, Brian M Feldman, Edward H Giannini, Frederick W Miller; International Myositis Assessment and Clinical Studies Group

Affiliations

PMID: 16142757
DOI: 10.1002/art.21291

Guideline

International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies

Chester V Oddis et al. Arthritis Rheum. 2005 Sep.

. 2005 Sep;52(9):2607-15.

doi: 10.1002/art.21291.

Authors

Chester V Oddis¹, Lisa G Rider, Ann M Reed, Nicolino Ruperto, Hermine I Brunner, Bhanu Koneru, Brian M Feldman, Edward H Giannini, Frederick W Miller; International Myositis Assessment and Clinical Studies Group

Affiliation

¹ University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA. oddis@dom.pitt.edu

PMID: 16142757
DOI: 10.1002/art.21291

No abstract available

PubMed Disclaimer

Similar articles

Defining Clinical Improvement in Adult and Juvenile Myositis.
Rider LG, Giannini EH, Harris-Love M, Joe G, Isenberg D, Pilkington C, Lachenbruch PA, Miller FW; International Myositis Assesment and Clinical Studies Group. Rider LG, et al. J Rheumatol. 2003 Mar;30(3):603-17. J Rheumatol. 2003. PMID: 12610824 Review.
Outcomes and disease activity measures for assessing treatments in the idiopathic inflammatory myopathies.
Oddis CV. Oddis CV. Curr Rheumatol Rep. 2005 Apr;7(2):87-93. doi: 10.1007/s11926-005-0059-y. Curr Rheumatol Rep. 2005. PMID: 15760586 Review.
119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands.
Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, Vencovsky J, de Visser M, Hughes RA. Hoogendijk JE, et al. Neuromuscul Disord. 2004 May;14(5):337-45. doi: 10.1016/j.nmd.2004.02.006. Neuromuscul Disord. 2004. PMID: 15099594 No abstract available.
Developing international consensus on measures of improvement for patients with myositis.
Lachenbruch PA, Miller FW, Rider LG. Lachenbruch PA, et al. Stat Methods Med Res. 2007 Feb;16(1):51-64. doi: 10.1177/0962280206070652. Stat Methods Med Res. 2007. PMID: 17338294
Advances in the therapy of idiopathic inflammatory myopathies.
Baer AN. Baer AN. Curr Opin Rheumatol. 2006 May;18(3):236-41. doi: 10.1097/01.bor.0000218942.12236.74. Curr Opin Rheumatol. 2006. PMID: 16582685 Review.

See all similar articles

Cited by

Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity.
Suzuki F, Kubota T, Miyazaki Y, Ishikawa K, Ebisawa M, Hirohata S, Ogura T, Mizusawa H, Imai T, Miyasaka N, Nanki T. Suzuki F, et al. Arthritis Res Ther. 2012 Mar 6;14(2):R48. doi: 10.1186/ar3761. Arthritis Res Ther. 2012. PMID: 22394569 Free PMC article.
Necrotizing fasciitis in a patient treated with etanercept for dermatomyositis.
Choi KH, Yoo WH. Choi KH, et al. Rheumatol Int. 2009 Feb;29(4):463-6. doi: 10.1007/s00296-008-0695-4. Epub 2008 Sep 16. Rheumatol Int. 2009. PMID: 18795294
Achieving Medication-Free Remission in Patients With Juvenile Dermatomyositis.
Maccora I, Brunner HI, Cassedy A, Altaye M, Quinlan-Waters M, Lovell DJ, Grom A, Angeles-Han ST. Maccora I, et al. ACR Open Rheumatol. 2025 Jan;7(1):e11751. doi: 10.1002/acr2.11751. Epub 2024 Dec 20. ACR Open Rheumatol. 2025. PMID: 39707697 Free PMC article.
Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
Gordon PA, Winer JB, Hoogendijk JE, Choy EH. Gordon PA, et al. Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD003643. doi: 10.1002/14651858.CD003643.pub4. Cochrane Database Syst Rev. 2012. PMID: 22895935 Free PMC article.
Muscle involvement in systemic sclerosis: points to consider in clinical trials.
Walker UA, Clements PJ, Allanore Y, Distler O, Oddis CV, Khanna D, Furst DE. Walker UA, et al. Rheumatology (Oxford). 2017 Sep 1;56(suppl_5):v38-v44. doi: 10.1093/rheumatology/kex196. Rheumatology (Oxford). 2017. PMID: 28992167 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

AR-48349-01/AR/NIAMS NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information